3B Future Health Fund

3B Future Health · Venture capital

UncertainLast verified 7 Nov 2026

Healthcare venture fund investing up to $12M in early-stage oncology and rare disease startups across Europe, the US, and Israel, typically entering at Series A or earlier.

0 deals in the last 24 months. Taken from its own website.

Key facts

Stages: Seed, Series A
Sectors: Biotech & pharma, Healthtech
Ticket: up to €12M
Eligible countries: Israel, United States
Timing: Rolling applications
Focus: oncology; rare diseases; healthcare; first-in-class assets
How to apply: Apply route unknown
Source: https://3bfuturehealth.com/

Recent deals

No deals in our data for the last 24 months.

Evidence

Short excerpts from the sources, in their original language, that back the facts above.

Kind3B Future Health Fund supports US and European-based private early-stage, innovative companieshttps://3bfuturehealth.com/
Sectors100% healthcare, early stage and clinical development stage. Therapeutic areas with strong unmet patient needs; priority on US and European-based startups…https://3bfuturehealth.com/
StagesWe typically make our initial investment in companies raising Series A rounds, but in some cases even earlier.https://3bfuturehealth.com/
TicketFund comprised of 10-15 companies, up to $12 million investment in eachhttps://3bfuturehealth.com/
TicketFund comprised of 10-15 companies, up to $12 million investment in eachhttps://3bfuturehealth.com/

Status history

7 Nov 2026: Rolling → Uncertain (freshness: investor activity)
6 Nov 2026: Rolling (first extraction)

Something wrong or out of date? Report an error.

Work at 3B Future Health? Claim this profile to confirm what you invest in.